Tesi
Finance · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Porkkalankatu 1, Helsinki, Uusimaa, 0018...Phone Number
+358 96803680Website
www.tesi.fiRevenue
$20.5 MillionIndustry
About Tesi
Tesi Org Chart
Is Tesi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check if Tesi has recently received funding, and reach out quickly before it becomes old news!
Tesi, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Tesi launches new products
Click to see if Tesi had a recent Job posting/layoffs
Check out if Tesi is spiking on competitors!
Earning: See what the market has to say on Tesi recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Tesi
Funding: Get notified immidiatlly once Tesi has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Tesi
Find 3 more new buyers
Company Profile Activity
Activity Insights
Tesi is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Tesi is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Tesi.
Tesi Tech Stack
A closer look at the technologies used by Tesi
Most Recent Scoops
Tesi News & Media
TILT Biotherapeutics Announces over $10 Million Financing to Advance Oncology Immunotherapy Assets
HELSINKI--(BUSINESS WIRE)--TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces it has completed the first close of its financing round raising $10.7 million (€10 million). The round was led by Lifeline Ventures and was joined by Tesi (Finnish Industry Investment Ltd). The funding will be used to advance Phase I/II programs in Europe and the US, using TILT-123 plus immune checkpoint inhibitors against a range of cancers including ovariUute Scientific secures a EUR 1.2 million funding round. - tesi.fi
Helsinki-based Uute Scientific, a startup drawing from both ecology and medicine, has completed a EUR 1.2 million funding round.Karma Ventures raises EUR 100 million fund with a focus on deep tech software startups - tesi.fi
Connecting the Finnish and Baltic ecosystems, the EUR 100 million fund by Karma Ventures invests in deep tech software companies.Onvest and Tesi to acquire a stake in Puurakentajat enabling the company to enter a new growth phase
Puurakentajat Oy Press Release 9 November 2021 at 10.00 a.m. (EET) Family company Onvest Oy has acquired a significant stake in Puurakentajat Group Oy, the Finnish expert in solid wood construction, and becomes an active industrial owner of the company. Furthermore, Tesi (Suomen Teollisuussijoitus Oy) has also acquired a stake in the company. The changing ownership structure enables Puurakentajat to develop its strongly growing operations to a new level. Wood construction is growing strongly bot
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tesi
Tesi (Finnish Industry Investment Ltd) is a venture capital and private equity company that accelerates companies' success stories by investing in them directly and via funds. Tesi always invests together with other investors, providing them with access to high quality deal-flow in Finland. Our investments under management total €1.2 billion and we... Read More